• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化合并脓毒症患者死亡的危险因素。

Risk factors for mortality in cirrhotic patients with sepsis.

机构信息

Department of Gastroenterology and Hepatology, National University Health System, Singapore, Singapore.

出版信息

Hepatol Int. 2011 Sep;5(3):800-7. doi: 10.1007/s12072-011-9258-y. Epub 2011 Feb 13.

DOI:10.1007/s12072-011-9258-y
PMID:21484126
Abstract

BACKGROUND

Patients with cirrhosis and sepsis had increased mortality.

AIM

Determine factors associated with increased in-hospital mortality in cirrhotic patients admitted for sepsis.

METHODS

All cirrhotic patients admitted from 2004 to 2007 for sepsis were identified from hospital electronic database. Patients were included if they had liver cirrhosis and sepsis, defined as identified sources of infection, and at least one of fever, altered total white cell count, or raised C-reactive protein. Baseline characteristics, investigations, infections, and outcomes were collected. Main outcome measure was in-hospital mortality.

RESULTS

A total of 205 admissions in 153 patients were included. In-hospital mortality rate was 24.4%. In predicting in-hospital death, area under the receiver-operating-characteristic curve for Child-Pugh score was 0.934, with optimum cut-off at 10 and above, while for model for end-stage liver disease (MELD) score was 0.751, with optimum cut-off at 17 and above. Four factors were significantly associated with in-hospital mortality on multivariate analysis: presence of >1 site of infection, pneumonia, Child's C status, and MELD score 17 and above. In-hospital mortality rate increased with more factors: 0% with no factor, 7% with one factor, 21% with two factors, 87% with three factors, and 100% with four factors. The mortality of those with <3 risk factors was significantly lower than those with three or more risk factors (7 vs. 91%, p = 0.000).

CONCLUSIONS

Septic cirrhotic patients with pneumonia, >1 site of infection, Child's C cirrhosis, and high MELD score had a high mortality risk.

摘要

背景

肝硬化合并脓毒症患者的死亡率增加。

目的

确定与肝硬化患者因脓毒症住院死亡率增加相关的因素。

方法

从医院电子数据库中确定 2004 年至 2007 年因脓毒症住院的所有肝硬化患者。如果患者有肝硬化和脓毒症,定义为确定感染源,且至少有发热、总白细胞计数改变或 C 反应蛋白升高,则将患者纳入研究。收集基线特征、检查、感染和结果。主要观察指标为住院死亡率。

结果

共纳入 153 例患者 205 例次住院。住院死亡率为 24.4%。在预测住院死亡方面,Child-Pugh 评分的受试者工作特征曲线下面积为 0.934,最佳截断值为 10 分以上,而终末期肝病模型(MELD)评分的曲线下面积为 0.751,最佳截断值为 17 分以上。多因素分析显示,存在>1 个感染部位、肺炎、Child C 状态和 MELD 评分 17 分以上是与住院死亡率相关的四个显著因素。住院死亡率随因素数量的增加而增加:无因素时为 0%,有 1 个因素时为 7%,有 2 个因素时为 21%,有 3 个因素时为 87%,有 4 个因素时为 100%。具有<3 个危险因素的患者死亡率显著低于具有 3 个或更多危险因素的患者(7%比 91%,p=0.000)。

结论

患有肺炎、>1 个感染部位、Child C 肝硬化和高 MELD 评分的脓毒症肝硬化患者死亡率高。

相似文献

1
Risk factors for mortality in cirrhotic patients with sepsis.肝硬化合并脓毒症患者死亡的危险因素。
Hepatol Int. 2011 Sep;5(3):800-7. doi: 10.1007/s12072-011-9258-y. Epub 2011 Feb 13.
2
Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score?将估算的肾小球滤过率纳入终末期肝病评分中是否比肌酐更好?
World J Hepatol. 2012 Nov 27;4(11):291-8. doi: 10.4254/wjh.v4.i11.291.
3
Model for end stage of liver disease (MELD) is better than the Child-Pugh score for predicting in-hospital mortality related to esophageal variceal bleeding.终末期肝病模型(MELD)在预测与食管静脉曲张破裂出血相关的住院死亡率方面优于Child-Pugh评分。
Ann Hepatol. 2008 Jul-Sep;7(3):230-4.
4
Low Absolute Eosinophil Count Predicts In-Hospital Mortality in Cirrhosis With Systemic Inflammatory Response Syndrome.低绝对嗜酸性粒细胞计数可预测伴有全身炎症反应综合征的肝硬化患者的院内死亡率。
Cureus. 2021 Jan 11;13(1):e12643. doi: 10.7759/cureus.12643.
5
Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection.终末期肝病模型(MELD)评分作为肝硬化感染患者有用的预后标志物。
J Coll Physicians Surg Pak. 2009 Nov;19(11):694-8.
6
A New Recalibrated Four-Category Child-Pugh Score Performs Better than the Original Child-Pugh and MELD Scores in Predicting In-Hospital Mortality in Decompensated Alcoholic Cirrhotic Patients with Acute Variceal Bleeding: a Real-World Cohort Analysis.一种新的校正四分类 Child-Pugh 评分在预测失代偿性酒精性肝硬化伴急性静脉曲张出血患者住院死亡率方面优于原始 Child-Pugh 和 MELD 评分:一项真实世界队列分析。
World J Surg. 2020 Jan;44(1):241-246. doi: 10.1007/s00268-019-05211-8.
7
D-dimer level for predicting the in-hospital mortality in liver cirrhosis: A retrospective study.D-二聚体水平预测肝硬化患者院内死亡率的回顾性研究。
Exp Ther Med. 2017 Jan;13(1):285-289. doi: 10.3892/etm.2016.3930. Epub 2016 Nov 28.
8
Low eosinophil count predicts in-hospital mortality in cirrhosis with systemic inflammatory response syndrome.低嗜酸性粒细胞计数可预测伴有全身炎症反应综合征的肝硬化患者的住院死亡率。
Eur J Gastroenterol Hepatol. 2013 Jun;25(6):676-82. doi: 10.1097/MEG.0b013e32835eb8f7.
9
Comparison of the predictive value of scoring systems on the prognosis of cirrhotic patients with suspected infection.评分系统对疑似感染肝硬化患者预后预测价值的比较
Medicine (Baltimore). 2018 Jul;97(28):e11421. doi: 10.1097/MD.0000000000011421.
10
Prognostic value of risk scoring systems for cirrhotic patients with variceal bleeding.肝硬化静脉曲张出血患者风险评分系统的预后价值。
World J Gastroenterol. 2019 Dec 7;25(45):6668-6680. doi: 10.3748/wjg.v25.i45.6668.

引用本文的文献

1
Assessing the prognosis of cirrhotic patients in the intensive care unit: What we know and what we need to know better.评估重症监护病房中肝硬化患者的预后:我们所知与我们需要更深入了解的内容。
World J Hepatol. 2021 Oct 27;13(10):1341-1350. doi: 10.4254/wjh.v13.i10.1341.
2
Sociodemographic characteristics, complications requiring hospital admission and causes of in-hospital death in patients with liver cirrhosis admitted at a district hospital in Ghana.加纳地区医院收治的肝硬化患者的社会人口学特征、需要住院治疗的并发症以及住院死亡原因。
PLoS One. 2021 Jun 24;16(6):e0253759. doi: 10.1371/journal.pone.0253759. eCollection 2021.
3

本文引用的文献

1
Acute-phase proteins as indicators of bacterial infection in patients with cirrhosis.急相蛋白作为肝硬化患者细菌感染的指标。
Liver Int. 2009 Nov;29(10):1538-42. doi: 10.1111/j.1478-3231.2009.02088.x. Epub 2009 Jul 31.
2
The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome.肝硬化患者的全身炎症反应综合征:与住院结局的关系。
J Hepatol. 2009 Sep;51(3):475-82. doi: 10.1016/j.jhep.2009.04.017. Epub 2009 May 26.
3
Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
Comparing Mortality Risk Predictive Ability of Different Scoring Systems in Cirrhotic Patients with Bacteremia.
比较不同评分系统对肝硬化菌血症患者的死亡风险预测能力。
Emerg Med Int. 2020 Oct 26;2020:8596567. doi: 10.1155/2020/8596567. eCollection 2020.
4
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies.用于评估肝硬化预后的Child-Pugh评分与终末期肝病模型(MELD)评分:观察性研究的系统评价和荟萃分析
Medicine (Baltimore). 2016 Feb;95(8):e2877. doi: 10.1097/MD.0000000000002877.
抑酸药物的使用与医院获得性肺炎的风险
JAMA. 2009 May 27;301(20):2120-8. doi: 10.1001/jama.2009.722.
4
Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.质子泵抑制剂治疗与肝硬化腹水患者自发性细菌性腹膜炎的关联。
Am J Gastroenterol. 2009 May;104(5):1130-4. doi: 10.1038/ajg.2009.80. Epub 2009 Mar 31.
5
New guidelines for the management of adult community-acquired pneumonia.成人社区获得性肺炎管理新指南。
Curr Opin Infect Dis. 2007 Apr;20(2):170-6. doi: 10.1097/QCO.0b013e3280803d70.
6
Guidelines on the management of ascites in cirrhosis.肝硬化腹水管理指南
Gut. 2006 Oct;55 Suppl 6(Suppl 6):vi1-12. doi: 10.1136/gut.2006.099580.
7
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.肝硬化中的脓毒症:国际腹水俱乐部第七次会议报告
Gut. 2005 May;54(5):718-25. doi: 10.1136/gut.2004.038679.
8
Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosis.肝硬化所致肝功能不全的大肠杆菌感染患者体内C反应蛋白的产生
Diagn Microbiol Infect Dis. 2005 Apr;51(4):227-30. doi: 10.1016/j.diagmicrobio.2004.11.014.
9
Bacterial translocation (BT) in cirrhosis.肝硬化中的细菌易位(BT)
Hepatology. 2005 Mar;41(3):422-33. doi: 10.1002/hep.20632.
10
Management of adult patients with ascites due to cirrhosis.肝硬化所致腹水成年患者的管理
Hepatology. 2004 Mar;39(3):841-56. doi: 10.1002/hep.20066.